Controversy
Status:Open
Will Annual Global Sales of GLP-1-Based Anti-Obesity and Diabetes Drugs Exceed $100B by 2028?
UNLIKELYLIKELY
Claims
Fortune Business Insights"The global anti-obesity drugs market size was valued at USD 4.51 billion in 2023 and is projected to grow from USD 6.15 billion in 2024 to USD 37.94 billion by 2032, exhibiting a CAGR of 25.5% during the forecast period (2024-2032)."Nov 10, 2025
Gabelli"We estimate about 12-15 million patients will be using GLP-1 drugs by 2030 across both indications, which translates to the market growing from ~$30B today to ~$80B by 2030."Apr 01, 2025
J.P. Morgan"J.P. Morgan Global Research forecasts that the global incretin market, which includes GLP-1s, will reach $200 billion by 2030."Jul 05, 2026
Goldman Sachs"Goldman Sachs Research forecasts the global market to reach $95 billion by 2030 — lower than its previous estimate of $130 billion."May 22, 2025
UBS Global Wealth Management"This [GLP-1 model forecast] translates into $126bn sales by 2029, a 2023-2029 sales CAGR of 30%."Nov 26, 2025
Teneo"Analysts project the global GLP-1RA market to reach between $75bn and $140bn by 2030."Jul 06, 2026
Harvest ETFs"The GLP-1 drug class boasts projected sales exceeding US $150 billion by 2030."Aug 15, 2025
Inizio Ignite"The U.S. obesity market alone is expected to exceed $100 billion by 2030."Jan 02, 2026
Grand View Research"The global GLP-1 agonists weight loss drugs market size was estimated at USD 13.84 billion in 2024 and is projected to reach USD 48.84 billion by 2030, growing at a CAGR of 18.54% from 2025 to 2030."Nov 26, 2025
BCC Research"According to BCC Research’s Global GLP-1 Analogues Market report, the market was valued at $54.8 billion in 2024 and is projected to reach $268.4 billion by 2030."Jan 30, 2026
Research and Markets"The global market for GLP-1 Receptor Agonist was valued at US$51.9 Billion in 2024 and is projected to reach US$137.4 Billion by 2030."Jul 05, 2026
TD Securities"Global GLP-1 sales in 2030 could reach US$139 billion, up from our US$101 billion forecast a little over a year ago."Nov 26, 2025
Edgen"The obesity therapeutics market is projected for significant expansion, targeting $20.84 billion by 2033 with a compound annual growth rate of 20.6%."Nov 26, 2025
TD Securities"Global sales of GLP-1, a medication used to manage blood sugar levels for those with Type 2 diabetes, is projected to reach US$139 billion by 2030."Nov 26, 2025
CNBC"Wall Street is betting big on the burgeoning industry, with estimates suggesting it could be worth upwards of $100 billion by 2030."Aug 26, 2025
UPS Healthcare"The global GLP-1 market is projected to exceed $100 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.6%."Jul 05, 2026
GlobalData"By 2031, GlobalData expects the obesity market to grow at a strong compound annual growth rate (CAGR) of 32.3%, reaching sales of $173.5 billion by the end of the forecast period."Jul 05, 2026
Go deeper
© 2026 Improve the News Foundation. All rights reserved.Version 7.4.1
© 2026 Improve the News Foundation.
All rights reserved.
Version 7.4.1